Eu­ro­pean drug reg­u­la­tors of­fer wave of pos­i­tive rec­om­men­da­tions fol­low­ing Leqem­bi re­ver­sal

The Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee hand­ed down a slew of pos­i­tive rec­om­men­da­tions for drugs on Fri­day, in­clud­ing Mer­ck’s block­buster can­cer drug Keytru­da and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER